Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-9.22M.
ENTERPRISE VALUE (EV)
$-9.22M
Evogene Ltd.
Market Cap
$3.74M
Enterprise Value (EV)
$-9.22M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Evogene Ltd. (EVGN) | $3.74M | $-9.22M |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.71M | N/A |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.70M | $7.07M |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.69M | $1.31M |
| Eocene Ltd. (EOCN)vs › | $3.56M | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.56M | $2.55M |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.87M | $3.00M |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.46M | N/A |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.97M | N/A |
Market Cap
$3.74M
Total Debt
$0.00
Cash
$12.96M
Enterprise Value
$-9.22M
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Why use EV instead of Market Cap?
